Smith & Nephew to buy U.S. wound care business for $782 mln
LONDON Nov 28 (Reuters) - Artificial hip and knee maker Smith & Nephew said it was expanding in the fast-growing area of bioactive wound care by acquiring privately-held U.S. firm Healthpoint.
S&N said it would pay $782 million in cash for the company, which makes Santyl, an ointment for the removal of dead tissue in wounds, and is in phase III trials for a treatment for leg ulcers.
Healthpoint had $190 million revenues in 2012 and S&N expects the deal to be accretive to earnings from 2013, it said on Wednesday.
- Obama and Castro shake hands, Zuma humiliated at Mandela memorial |
- Google bus blocked in San Francisco gentrification protest
- Reporter can keep sources secret in Colorado theater shooting: court
- Regulators seek to curb Wall St. trades with Volcker rule
- Thai PM urges protesters to take part in election |